End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18.9 THB | -1.56% | -2.07% | -15.62% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The company returns high margins, thereby supporting business profitability.
- The company is in a robust financial situation considering its net cash and margin position.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company benefits from high valuations in earnings multiples.
- With an enterprise value anticipated at 3.55 times the sales for the current fiscal year, the company turns out to be overvalued.
- The company appears highly valued given the size of its balance sheet.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-15.62% | 1.28B | B- | ||
-23.39% | 15.56B | B+ | ||
-2.70% | 11.65B | B | ||
+2.65% | 11.58B | B+ | ||
+2.37% | 10.06B | B+ | ||
-10.45% | 7.16B | A- | ||
+8.05% | 6.85B | B- | ||
-4.29% | 5.71B | D | ||
+13.33% | 4.3B | B+ | ||
-3.96% | 4.3B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BCH Stock
- Ratings Bangkok Chain Hospital